Guangdong Provincial People's Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- -
- Market Cap
- -
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
Phase 2
Recruiting
- Conditions
- RET Driver MutationErb-B2 Receptor Tyrosine Kinase Exon 20 MutationNon-Small Cell Lung CancerBRAF V600 MutationMET AmplificationMET Exon 14 Skipping Mutation
- Interventions
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05800340
- Locations
- 🇨🇳
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guanzhou, Guangdong, China
Induction Lorlatinib in Stage III Non-small Cell Lung Cancer
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT05740943
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
Recruiting
- Conditions
- Oligometastatic DiseaseNon-small Cell Lung Cancer
- Interventions
- Genetic: ctDNA testing and whole exome sequencing
- First Posted Date
- 2022-12-13
- Last Posted Date
- 2022-12-13
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05648370
- Locations
- 🇨🇳
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China
Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC
Completed
- Conditions
- ChemotherapyTumour, ResidualNon Small Cell Lung CancerImmunotherapy
- Interventions
- Drug: Timing of drug administration
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 110
- Registration Number
- NCT05637580
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
International Big Data Centre in Emergency Medicine
Recruiting
- Conditions
- Emergency Medicine
- First Posted Date
- 2022-11-15
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 500000
- Registration Number
- NCT05616416
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
Completed
- Conditions
- Esophagus Cancer
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 350
- Registration Number
- NCT05615129
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer
Recruiting
- Conditions
- Esophageal Cancer
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05615103
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
Phase 2
Recruiting
- Conditions
- Patient-reported OutcomesImmunotherapyEsophageal Squamous Cell Carcinoma
- Interventions
- Drug: Paclitaxel-albuminRadiation: VMAT or IMRTProcedure: Esophagectomy
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2022-11-28
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05596890
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Analysis of Factors and Treatment Related to Chronic Cough After Pulmonary Resection
Recruiting
- Conditions
- Persistent CoughPneumonectomyLung Neoplasms
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05586035
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Treatment Free Remission (TFR) in CML Patients （CML-CP）Study
Not yet recruiting
- Conditions
- Chronic Myeloid LeukemiaTreatment-free Remission
- Interventions
- Other: TFR(Treatment-Free Remission)
- First Posted Date
- 2022-07-01
- Last Posted Date
- 2022-07-01
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 203
- Registration Number
- NCT05440747
© Copyright 2025. All Rights Reserved by MedPath